Artemis Medicare Services Ltd

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO. This rating was last updated on 08 June 2026, reflecting a shift from a previous Hold stance. However, the analysis and financial metrics presented here are based on the company’s current position as of 21 June 2026, providing investors with the latest insights into its performance and outlook.

Artemis Medicare Services Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 10 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade in daily price performance, key technical indicators reveal a complex interplay of bullish and bearish signals, prompting a reassessment of the stock’s near-term trajectory.

Artemis Medicare Services Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a bullish stance on daily moving averages. Despite a recent 1.25% decline in price to ₹268.25, the stock’s technical indicators present a nuanced picture, with weekly signals largely positive while monthly metrics remain cautiously mixed. This article analyses the evolving technical landscape of Artemis Medicare, placing it in the context of its sector and broader market performance.

The 50-day moving average has crossed above the 200-day moving average for Artemis Medicare Services Ltd, signalling a golden cross on 3 Jun 2026. Yet, the stock declined 1.25% on the same day, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the technical and fundamental context behind the crossover.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment as the stock navigates recent volatility.

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO. This rating was last updated on 25 May 2026, reflecting a shift from the previous Hold status. However, the analysis and financial metrics presented here are based on the company’s current position as of 30 May 2026, providing investors with the latest insights into its performance and outlook.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a modest day change of 0.05%, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid broader market volatility.

Artemis Medicare Services Ltd, a prominent player in the hospital sector, has seen its investment rating downgraded from Buy to Hold as of 18 May 2026. This revision reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust financial performance and operational strength, evolving market dynamics and technical indicators have prompted a more cautious stance among analysts.

Artemis Medicare Services Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s mixed technical indicators suggest a complex outlook for investors navigating the current market environment.

Artemis Medicare Services Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, effective from 11 May 2026, underscores the company’s robust operational performance, attractive valuation metrics, and positive market momentum within the hospital sector.

Artemis Medicare Services Ltd has recently seen its quality grade upgraded from average to good, reflecting significant improvements in its business fundamentals. This upgrade, accompanied by a Mojo Score rise to 71.0 and a Buy rating, signals enhanced operational efficiency, stronger returns, and better financial health. Investors should consider how these changes position the company within the competitive hospital sector and what it means for future growth prospects.

While the Sensex declined by 1.41% on 11 Jun 2026, Artemis Medicare Services Ltd surged 7.48%, touching an intraday high of Rs 289.25. This 8.21-percentage-point outperformance over its Hospital sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Artemis Medicare Services Ltd., the Gurugram-based multi-speciality hospital operator, reported a robust 30.40% year-on-year surge in consolidated net profit to ₹30.03 crores for Q4 FY26, marking its strongest quarterly performance to date. The ₹4,149 crore market capitalisation company delivered revenue of ₹279.23 crores for the March quarter, up 16.39% YoY, as patient volumes and average revenue per occupied bed continued their upward trajectory.